{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:13:01Z","timestamp":1777317181154,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40261-015-0343-1","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T22:39:05Z","timestamp":1444257545000},"page":"807-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers"],"prefix":"10.1007","volume":"35","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiru","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"343_CR1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1398-9995.2006.01277.x","volume":"62","author":"GW Canonica","year":"2007","unstructured":"Canonica GW, Tarantini F, Compalati E, Penagos M. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Allergy. 2007;62:359\u201366.","journal-title":"Allergy"},{"key":"343_CR2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1468-3083.2008.03034.x","volume":"23","author":"M Augustin","year":"2009","unstructured":"Augustin M, Ehrle S. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients. J Eur Acad Dermatol. 2009;23:292\u201399.","journal-title":"J Eur Acad Dermatol."},{"key":"343_CR3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1067\/mai.2001.114239","volume":"107","author":"RS Geha","year":"2001","unstructured":"Geha RS, Meltzer EO. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol. 2001;107:751\u201362.","journal-title":"J Allergy Clin Immunol."},{"key":"343_CR4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/13543784.10.3.547","volume":"10","author":"DK Agrawal","year":"2001","unstructured":"Agrawal DK. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug. Expert Opin Investig Drugs. 2001;10:547\u201360.","journal-title":"Expert Opin Investig Drugs"},{"key":"343_CR5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0149-2918(01)80049-7","volume":"23","author":"S Gupta","year":"2001","unstructured":"Gupta S, Banfield C, Kantesaria B, Marino M, Clement R, Affrime M, Batra V. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. Clin Ther. 2001;23:451\u201366.","journal-title":"Clin Ther"},{"key":"343_CR6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jpba.2007.07.012","volume":"45","author":"HR Xu","year":"2007","unstructured":"Xu HR, Li XN, Chen WL, Chu NN. Simultaneous determination of desloratadine and its active metabolite 3-hydroxydesloratadine in human plasma by LC\/MS\/MS and its application to pharmacokinetics and bioequivalence. J Pharm Biomed Anal. 2007;45:659\u201366.","journal-title":"J Pharm Biomed Anal"},{"key":"343_CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpha.2012.01.008","volume":"2","author":"VS Ponnuru","year":"2012","unstructured":"Ponnuru VS, Challa BR, Nadendla R. Quantification of desloaratadine in human plasma by LC-ESI-MS\/MS and application to a pharmacokinetic study. J Pharm Biomed Anal. 2012;2:180\u201387.","journal-title":"J Pharm Biomed Anal"},{"key":"343_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1570-0232(03)00267-8","volume":"792","author":"L Yang","year":"2003","unstructured":"Yang L, Clement RP, Kantesaria B, Reyderman L, Beaudry F, Grandmaison C, Di Donato L, Masse R, Rudewicz PJ. Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;792:229\u201340.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"343_CR9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/00498250701463325","volume":"37","author":"R Ramanathan","year":"2007","unstructured":"Ramanathan R, Reyderman L, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE. Disposition of desloratadine in healthy volunteers. Xenobiotica. 2007;37:770\u201387.","journal-title":"Xenobiotica"},{"key":"343_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-200241001-00002","volume":"41","author":"S Gupta","year":"2002","unstructured":"Gupta S, Banfield C, Affrime M, Marbury T, Padhi D, Glue P. Oral bioavailability of desloratadine is unaffected by food. Clin Pharmacokinet. 2002;41:7\u201312.","journal-title":"Clin Pharmacokinet"},{"key":"343_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003088-200241001-00004","volume":"41","author":"M Affrime","year":"2002","unstructured":"Affrime M, Banfield C, Gupta S, Cohen A, Boutros T, Thonoor M, Cayen M. Effect of race and sex on single and multiple dose pharmacokinetics of desloratadine. Clin Pharmacokinet. 2002;41:21\u201388.","journal-title":"Clin Pharmacokinet"},{"key":"343_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/bdd.1770","volume":"33","author":"N Hakooz","year":"2012","unstructured":"Hakooz N, Salem II. Prevalence of desloratadine poor metabolizer phenotype in healthy Jordanian males. Biopharm Drug Dispos. 2012;33:15\u201321.","journal-title":"Biopharm Drug Dispos"},{"key":"343_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14740338.5.2.211","volume":"5","author":"P Bruce","year":"2006","unstructured":"Bruce P, Kenneth K, Samir G, Khalilieh S, Kantesaria B, Manitpisitkul P, Lorber R, Wang Z, Lutsky B. Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety. Expert Opin Drug Saf. 2006;5:211\u201323.","journal-title":"Expert Opin Drug Saf."},{"key":"343_CR14","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/j.jaci.2004.01.163","volume":"113","author":"RA Blum","year":"2004","unstructured":"Blum RA, Frick G, Kovacs SJ, Meeves S, Georges G, Kraft W. Clinical implications of the desloratadine slow metabolizer (DSM) phenotype based on pharmacokinetic (PK) principles. J Allergy Clin Immunol. 2004;113:S200.","journal-title":"J Allergy Clin Immunol."},{"key":"343_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.2047-2927.2014.00216.x","volume":"2","author":"P Surampudi","year":"2004","unstructured":"Surampudi P, Page ST, Swerdloff RS, Nya-Ngatchou JJ, Liu PY, Amory JK, Leung A, Hull L, Blithe DL, Woo J, Bremner WJ, Wang C. A first in human study of the pharmacokinetics, safety and food effects of orally administered DMAU: a prototype oral male hormonal contraceptive. Andrology. 2004;2:579\u201387.","journal-title":"Andrology."},{"key":"343_CR16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clinthera.2013.02.014","volume":"35","author":"J Lee","year":"2013","unstructured":"Lee J, Zhang W, Moy S, Kowalski D, Kowalski D, Kerbusch V, van Gelderen M, Sawamoto T, Grunenberg N, Keirns J. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults. Clin Ther. 2013;35:333\u201341.","journal-title":"Clin Ther"},{"key":"343_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00001813-200603000-00015","volume":"17","author":"CL Bello","year":"2006","unstructured":"Bello CL, Sherman L, Zhou J, Verkh L, Smeraglia J, Mount J, Klamerus KJ. Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects. Anti Cancer Drug. 2006;17:353\u201358.","journal-title":"Anti Cancer Drug."},{"key":"343_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2296-3-14","volume":"3","author":"LM Salmun","year":"2002","unstructured":"Salmun LM, Lorber R. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis. BMC Fam Pract. 2002;3:14.","journal-title":"BMC Fam Pract."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-015-0343-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0343-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:28:56Z","timestamp":1559489336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-015-0343-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1007\/s40261-015-0343-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}